Drug-induced cholestasis (DIC) is measured in vitro by the compound's ability to inhibit bile salt export pump (BSEP), however, DIC is typically complex, multifactorial and delayed in its manifestation [27–29], and therefore innovative toxicity models are required. The gene discussed is ABCB11; the disease is cholestasis.